Sen J, Groenewald C, Hiscott PS, Smith PA, Damato BE. Transretinal Choroidal Tumor Biopsy with a 25-Gauge Vitrector.
Ophthalmology 2006;
113:1028-31. [PMID:
16751041 DOI:
10.1016/j.ophtha.2006.02.048]
[Citation(s) in RCA: 62] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2005] [Accepted: 02/14/2006] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE
To describe and evaluate transretinal biopsy of choroidal tumors using 25-gauge vitrectomy instrumentation.
DESIGN
Retrospective, consecutive, noncomparative case series.
PARTICIPANTS
Fourteen patients undergoing choroidal tumor biopsy at an ocular oncology center.
METHODS
The biopsies were performed under local or general anesthesia, alone or in combination with ruthenium plaque or tantalum marker insertion. Immunohistochemistry was performed on all samples, and some melanomas were also analyzed cytogenetically.
RESULTS
Surgery was uneventful in all cases. A positive tissue diagnosis was made in 13 of 14 patients, albeit at the second attempt in 1 patient. The only failure occurred because the tumor was calcified.
CONCLUSION
Transretinal choroidal biopsy with 25-gauge instrumentation yields a larger sample than fine-needle aspiration biopsy, usually producing sufficient tissue for cytogenetic studies. We did not identify safety concerns in this series of patients. Insufficient samples can occur in some patients, and further studies are needed to understand the reason for such failure.
Collapse